Drug news
Jaydress (Bayer)levonorgestrel-releasing intrauterine contraceptive is EU approved
Bayer HealthCare has successfully concluded the European registration procedure for its new low dose levonorgestrel-releasing intrauterine system (IUS) called Jaydress. This long-term contraceptive is placed in the uterus for the prevention of pregnancy for up to three years. Sweden served as Reference Member State for the Decentralized Procedure to gain EU-wide marketing authorization for the new IUS. Based on the positive conclusion, the Health Authorities of the EU Member States will grant national approvals in the coming weeks and months. First launches of the product in the EU are expected in the second quarter of 2013.